Eli Lilly has experienced a dramatic increase of 505.84% in stock prices since 2020, transitioning from a $100 billion to a $740 billion market cap, potentially indicating a future stock split.
Analysts from 24/7 Wall Street focus on projected revenue and net income rather than historical growth rates to more accurately estimate future stock prices for Eli Lilly from 2025 to 2030.
Recent market news indicates Eli Lilly's stock is rising in response to a proposal from President Biden for Medicaid and Medicare to cover weight-loss drugs, potentially boosting demand for products like Mounjaro.
Concerns have emerged regarding Eli Lilly's inventory and receivables relative to sales which led to a downgrade by Ersete Group from 'Buy' to 'Hold', casting shadows on future growth despite a promising pipeline.
Collection
[
|
...
]